Sri Krishna Pharmaceuticals Limited
Sri Krishna Pharmaceuticals Limited, often referred to as SKPL, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1975, the company has made significant strides in the production of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a strong operational presence across various regions, SKPL focuses on a diverse range of therapeutic segments, including anti-infectives, cardiovascular, and central nervous system medications. The company is renowned for its commitment to quality and innovation, offering unique products that meet stringent regulatory standards. Over the years, Sri Krishna Pharmaceuticals has achieved notable milestones, solidifying its market position as a trusted supplier in the pharmaceutical sector. Its dedication to research and development, coupled with a robust manufacturing infrastructure, underscores its reputation for excellence in the industry.
DitchCarbon Score
How does Sri Krishna Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sri Krishna Pharmaceuticals Limited's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sri Krishna Pharmaceuticals Limited's reported carbon emissions
Sri Krishna Pharmaceuticals Limited, headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Sri Krishna Pharmaceuticals may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Sri Krishna Pharmaceuticals to establish clear climate commitments and reduction initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sri Krishna Pharmaceuticals Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
